A groundbreaking trial to test bone marrow stem cell therapy with a small group of patients with multiple sclerosis (MS) has been shown to have possible benefits for the treatment of the disease. The research team, led by Neil Scolding, Burden Professor of Clinical Neurosciences for the University of Bristol and North Bristol NHS Trust, have now completed a small trial in patients with MS to begin translating these findings from the laboratory to the clinic.
Will we ever see treatment here?
http://www.sciencedaily.com/releases/2010/05/100505113237.htm
Will we ever see treatment here?
http://www.sciencedaily.com/releases/2010/05/100505113237.htm